Dr Sigal Meilin is currently the director of MD Biosciences Neurology Services lab in Ness Ziona Israel. Under her direction, the lab has established and developed a range of disease models in pain, stroke, CNS/neurodegeneration and cardiovascular. Prior
to joining MD Biosciences in 2006, she served as the director of Pharmacological studies and head of the histology department at Pharmos in Ness Ziona. She received her PhD from Bar-Ilan University. Her post doctoral studies involved the cross-talk between inflammation and apoE genotype in Alzheimers disease at Tel Aviv University department of neuro-biochemistry.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)